As well, this experimental model is suitable for studying cardiac disease mechanisms and exploring therapeutic options for patients under IGF-1 deficiency conditions such as ageing, metabolic syndrome, advanced cirrhosis. This evidence concerns the gene IGF1 and Cirrhosis.